AA
STJ

AQR Arbitrage’s St Jude Medical STJ Stock Holding History

AQR Arbitrage’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,017,276
Closed -$162M – 409
2016
Q4 		$162M Sell
2,017,276
-65,070
-3% -$5.16M 1.68% 13
2016
Q3 		$166M Buy
2,082,346
+371,568
+22% +$30M 1.63% 15
2016
Q2 		$133M Buy
+1,710,778
New +$122M 1.44% 16

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

AQR Arbitrage's STJ Position: Q1 2017 in Review

AQR Arbitrage sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,017,276 shares — an estimated $162M sold.

AQR Arbitrage first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $166M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • AQR Arbitrage reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • AQR Arbitrage sold 2,017,276 St Jude Medical shares in Q1 2017, an estimated $162M.
  • AQR Arbitrage first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • AQR Arbitrage's St Jude Medical position peaked at $166M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on AQR Arbitrage's 13F filing for Q1 2017, filed 15 May 2017.